Gilliland A, Chan JJ, De Wolfe TJ, Yang H, Vallance BA. Pathobionts in Inflammatory Bowel Illness: origins, underlying mechanisms, and implications for Medical Care. Gastroenterology. 2024;166:44–58.
Lewis JD, Parlett LE, Jonsson Funk ML, Brensinger C, Pate V, Wu Q, Dawwas GK, Weiss A, Fixed BD, McCauley M, et al. Incidence, prevalence, and racial and ethnic distribution of inflammatory bowel illness in the US. Gastroenterology. 2023;165:1197–e12051192.
Zhang J, Xu M, Zhou W, Li D, Zhang H, Chen Y, Ning L, Zhang Y, Li S, Yu M, et al. Deficiency within the anti-apoptotic protein DJ-1 promotes intestinal epithelial cell apoptosis and aggravates inflammatory bowel illness through p53. J Biol Chem. 2020;295:4237–51.
Kotla NG, Isa ILM, Rasala S, Demir S, Singh R, Child BV, Swamy SK, Dockery P, Jala VR, Rochev Y, Pandit A. Modulation of Intestine Barrier features in Ulcerative Colitis by Hyaluronic Acid System. Adv Sci 2021, 9.
Dulai PS, Singh S, Jairath V, Wong E, Narula N. Integrating proof to Information Use of Biologics and Small molecules for Inflammatory Bowel illnesses. Gastroenterology. 2024;166:396–408. e392.
Li J, Niu C, Ai H, Li X, Zhang L, Lang Y, Wang S, Gao F, Mei X, Yu C, et al. TSP50 attenuates DSS-Induced colitis by regulating TGF-beta signaling mediated upkeep of Intestinal Mucosal Barrier Integrity. Adv Sci (Weinh). 2024;11:e2305893.
Takahashi T, Shiga H, Tarasawa Ok, Shimoyama Y, Naito T, Moroi R, Kuroha M, Kakuta Y, Fushimi Ok, Fujimori Ok, et al. Comparative effectiveness of Tacrolimus and Infliximab in hospitalized sufferers with Ulcerative Colitis. Clin Transl Gastroenterol. 2024;15:e00642.
Kreijne JE, Goetgebuer RL, Erler NS, De Boer NK, Siebers AG, Dijkstra G, van Kemenade FA, Hoentjen F, Oldenburg B, van der Meulen AE, et al. Cumulative publicity to immunomodulators will increase danger of cervical neoplasia in girls with inflammatory bowel illness. Aliment Pharmacol Ther. 2023;58:207–17.
Singh S, Allegretti JR, Siddique SM, Terdiman JP. AGA Technical Evaluation on the administration of reasonable to extreme Ulcerative Colitis. Gastroenterology. 2020;158:1465–e14961417.
Zhang Z, Pan Y, Guo Z, Fan X, Pan Q, Gao W, Luo Ok, Pu Y, He B. An olsalazine nanoneedle-embedded inulin hydrogel reshapes intestinal homeostasis in inflammatory bowel illness. Bioactive Mater. 2024;33:71–84.
Zeeshan M, Ain QU, Sunny A, Raza F, Mohsin M, Khan S, Weigmann B, Ali H. QbD-based fabrication of transferrin-anchored nanocarriers for focused drug supply to macrophages and colon cells for mucosal irritation therapeutic. Biomater Sci. 2023;11:1373–97.
Tahara Ok, Samura S, Tsuji Ok, Yamamoto H, Tsukada Y, Bando Y, Tsujimoto H, Morishita R, Kawashima Y. Oral nuclear factor-κB decoy oligonucleotides supply system with chitosan modified poly(d,l-lactide-co-glycolide) nanospheres for inflammatory bowel illness. Biomaterials. 2011;32:870–8.
Ali H, Weigmann B, Neurath MF, Collnot EM, Windbergs M, Lehr CM. Budesonide loaded nanoparticles with pH-sensitive coating for improved mucosal focusing on in mouse fashions of inflammatory bowel illnesses. J Management Launch. 2014;183:167–77.
Bai X, Feng Z, Peng S, Zhu T, Jiao L, Mao N, Gu P, Liu Z, Yang Y, Wang D. Chitosan-modified Phellinus Igniarius Polysaccharide PLGA nanoparticles ameliorated inflammatory bowel illness. Biomater Adv. 2022;139:213002.
Mao Q, Pan H, Zhang Y, Zhang Y, Zhu Q, Hong Y, Huang Z, Li Y, Feng X, Fang Y, et al. GelNB molecular coating as a biophysical barrier to isolate intestinal irritating metabolites and regulate intestinal microbial homeostasis within the therapy of inflammatory bowel illness. Bioactive Mater. 2023;19:251–67.
Marotti V, Xu Y, Bohns Michalowski C, Zhang W, Domingues I, Ameraoui H, Moreels TG, Baatsen P, Van Hul M, Muccioli GG, et al. A nanoparticle platform for mixed mucosal therapeutic and immunomodulation in inflammatory bowel illness therapy. Bioactive Mater. 2024;32:206–21.
Monajemi H, Meenan J, Lamping R, Obradov DO, Radema SA, Trown PW, Tytgat GN, Van Deventer SJ. Inflammatory bowel illness is related to elevated mucosal ranges of bactericidal/permeability-increasing protein. Gastroenterology. 1996;110:733–9.
Canny G, Levy O, Furuta GT, Narravula-Alipati S, Sisson RB, Serhan CN, Colgan SP. Lipid mediator-induced expression of bactericidal/ permeability-increasing protein (BPI) in human mucosal epithelia. Proc Natl Acad Sci. 2002;99:3902–7.
Li X, Lu C, Yang Y, Yu C, Rao Y. Website-specific focused drug supply programs for the therapy of inflammatory bowel illness. Biomed Pharmacother. 2020;129:110486.
Zhang S, Langer R, Traverso G. Nanoparticulate Drug Supply programs Concentrating on irritation for therapy of inflammatory bowel illness. Nano As we speak. 2017;16:82–96.
Zhang S, Ermann J, Succi MD, Zhou A, Hamilton MJ, Cao B, Korzenik JR, Glickman JN, Vemula PK, Glimcher LH, et al. An inflammation-targeting hydrogel for native drug supply in inflammatory bowel illness. Sci Transl Med. 2015;7:300ra128.
Solar W, Chen Y, Wang L, Wang Z, Liu S, Zhang M, Liu Y, Li Q, Zhang H. Gram-scale preparation of quercetin supramolecular nanoribbons for intestinal inflammatory illnesses by oral administration. Biomaterials. 2023;295:122039.
Nie M, Huang D, Chen G, Zhao Y, Solar L. Bioadhesive Microcarriers Encapsulated with IL-27 excessive expressive MSC Extracellular vesicles for inflammatory bowel Illness Therapy. Adv Sci 2023.
Zhu Y, Wang Y, Xia G, Zhang X, Deng S, Zhao X, Xu Y, Chang G, Tao Y, Li M, et al. Oral supply of Bioactive Glass-Loaded Core-Shell Hydrogel microspheres for Efficient Therapy of Inflammatory Bowel Illness. Adv Sci (Weinh) 2023:e2207418.
Bovone G, Dudaryeva OY, Marco-Dufort B, Tibbitt MW. Engineering Hydrogel Adhesion for Biomedical Functions through Chemical Design of the Junction. ACS Biomater Sci Eng. 2021;7:4048–76.
Nam S, Mooney D. Polymeric tissue adhesives. Chem Rev. 2021;121:11336–84.
Lin S, Mukherjee S, Li J, Hou W, Pan C, Liu J. Mucosal immunity-mediated modulation of the intestine microbiome by oral supply of probiotics into Peyer’s patches. Sci Adv 2021, 7.
Li J, Hou W, Lin S, Wang L, Pan C, Wu F, Liu J. Polydopamine nanoparticle-mediated dopaminergic immunoregulation in colitis. Adv Sci (Weinh). 2022;9:e2104006.
Liu H, Cai Z, Wang F, Hong L, Deng L, Zhong J, Wang Z, Cui W. Colon-targeted Adhesive Hydrogel Microsphere for Regulation of Intestine immunity and Flora. Adv Sci (Weinh). 2021;8:e2101619.
He H, Qin Q, Xu F, Chen Y, Rao S, Wang C, Jiang X, Lu X, Xie C. Oral polyphenol-armored nanomedicine for focused modulation of intestine microbiota–mind interactions in colitis. Sci Adv 2023, 9.
Zhao P, Xia X, Xu X, Leung KKC, Rai A, Deng Y, Yang B, Lai H, Peng X, Shi P, et al. Nanoparticle-assembled bioadhesive coacervate coating with extended gastrointestinal retention for inflammatory bowel illness remedy. Nat Commun. 2021;12:7162.
Peng X, Xia X, Xu X, Yang X, Yang B, Zhao P, Yuan W, Chiu PWY, Bian L. Ultrafast self-gelling powder mediates sturdy moist adhesion to advertise therapeutic of gastrointestinal perforations. Sci Adv 2021, 7.
Fu JY, Lai YX, Zheng SS, Wang J, Wang YX, Ren KF, Yu L, Fu GS, Ji J. Mir-22-incorporated polyelectrolyte coating prevents intima hyperplasia after balloon-induced vascular damage. Biomater Sci 2022.
Xue B, Gu J, Li L, Yu W, Yin S, Qin M, Jiang Q, Wang W, Cao Y. Hydrogel tapes for fault-tolerant robust moist adhesion. Nat Commun. 2021;12:7156.
Yao W, Tune Z, Ma X, Huang Y, Zhang X, Li Y, Wei P, Zhang J, Xiong C, Yang S, et al. Uneven adhesive SIS-based wound dressings for therapeutically focusing on wound restore. J Nanobiotechnol 2024, 22.
Yuk H, Varela CE, Nabzdyk CS, Mao XY, Padera RF, Roche ET, Zhao XH. Dry double-sided tape for adhesion of moist tissues and gadgets. Nature. 2019;575:169–.
Yuk H, Wu J, Sarrafian TL, Mao X, Varela CE, Roche ET, Griffiths LG, Nabzdyk CS, Zhao X. Fast and coagulation-independent haemostatic sealing by a paste impressed by barnacle glue. Nat Biomedical Eng. 2021;5:1131–42.
Mei X, Li J, Wang Z, Zhu D, Huang Ok, Hu S, Popowski KD, Cheng Ok. An inhaled bioadhesive hydrogel to protect non-human primates from SARS-CoV-2 an infection. Nat Mater 2023.
Chen X, Yuk H, Wu J, Nabzdyk CS, Zhao X. Instantaneous robust bioadhesive with triggerable benign detachment. Proc Natl Acad Sci U S A. 2020;117:15497–503.
Wu J, Yuk H, Sarrafian TL, Guo CF, Griffiths LG, Nabzdyk CS, Zhao X. An off-the-shelf bioadhesive patch for sutureless restore of gastrointestinal defects. Sci Transl Med 2022, 14.
Wirtz S, Popp V, Kindermann M, Gerlach Ok, Weigmann B, Fichtner-Feigl S, Neurath MF. Chemically induced mouse fashions of acute and persistent intestinal irritation. Nat Protoc. 2017;12:1295–309.
El-Hammadi MM, Arias JL. Current advances within the Floor functionalization of PLGA-Primarily based nanomedicines. Nanomaterials 2022, 12.
Wang XW, Yin YJ, Wang J, Yu HM, Tang Q, Chen ZY, Fu GS, Ren KF, Ji J, Yu L. UV-Triggered hydrogel coating of the double community polyelectrolytes for enhanced endothelialization. Adv Sci (Weinh) 2024:e2401301.
Hu J-Q, Huang W-P, Wang J, Ren Ok-F, Ji J. UV-triggered polymerization of Polyelectrolyte Composite Coating with pore formation and lubricant infusion. Chin J Polym Sci. 2022;41:365–72.
Kotla NG, Singh R, Child BV, Rasala S, Rasool J, Hynes SO, Martin D, Egan LJ, Vemula PK, Jala VR, et al. Irritation-specific focused carriers for native drug supply to inflammatory bowel illness. Biomaterials 2022, 281.
Yoshino T, Nakase H, Honzawa Y, Matsumura Ok, Yamamoto S, Takeda Y, Ueno S, Uza N, Masuda S, Inui Ok, Chiba T. Immunosuppressive results of tacrolimus on macrophages ameliorate experimental colitis. Inflamm Bowel Dis. 2010;16:2022–33.
Ouahed JD, Griffith A, Collen LV, Snapper SB. Breaking down limitations: epithelial contributors to monogenic IBD pathogenesis. Inflamm Bowel Dis 2024.
Tsukita S, Tanaka H, Tamura A. The claudins: from tight junctions to Organic programs. Traits Biochem Sci. 2019;44:141–52.
Martins C, Sousa F, Araujo F, Sarmento B. Functionalizing PLGA and PLGA derivatives for drug supply and tissue regeneration functions. Adv Healthc Mater 2018, 7.
Lu X, Miao L, Gao W, Chen Z, McHugh KJ, Solar Y, Tochka Z, Tomasic S, Sadtler Ok, Hyacinthe A, et al. Engineered PLGA microparticles for long-term, pulsatile launch of STING agonist for most cancers immunotherapy. Sci Transl Med 2020, 12.
Zhang J, Solar H, Gao C, Wang Y, Cheng X, Yang Y, Gou Q, Lei L, Chen Y, Wang X, et al. Improvement of a chitosan-modified PLGA nanoparticle vaccine for cover towards Escherichia coli K1 brought on meningitis in mice. J Nanobiotechnol 2021, 19.
Govindarajan Ok, Kar S. Detection of β-amyloid aggregates/plaques in 5xFAD mice by labelled native PLGA nanoparticles: implication within the analysis of Alzheimer’s illness. J Nanobiotechnol 2023, 21.
Ma J-C, Luo T, Feng B, Huang Z, Zhang Y, Huang H, Yang X, Wen J, Bai X, Cui Z-Ok. Exploring the translational potential of PLGA nanoparticles for intra-articular rapamycin supply in osteoarthritis remedy. J Nanobiotechnol 2023, 21.
